Broadfin Capital LLC 13D/13G Filings for Strongbridge Biopharma plc (SBBP)

Broadfin Capital LLC 13D and 13G filings for Strongbridge Biopharma plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-02-13
5:20 pm
Sale
2019-12-3113GStrongbridge Biopharma plc
SBBP
Broadfin Capital LLC600,000
1.090%
-2,221,722decrease
(-78.74%)
Filing